Shema Oral Liquid Ameliorates the Severity of LPS-Induced COPD via Regulating DNMT1

• Päätekijät: Fangbo Zhang (Tekijä), Feifei Guo (Tekijä), Yang Liu (Tekijä), Yi Zhang (Tekijä), Defeng Li (Tekijä), Hongjun Yang (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background: Chronic obstructive pulmonary disease (COPD) is the most common respiratory disease with high morbidity and mortality. Shema oral liquid (Shema) is a traditional Chinese medicine (TCM) approved for the treatment of respiratory diseases. Clinical applications have shown that Shema has ant...